Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Long-Term Investments (2025)

Beta Bionics' Long-Term Investments history spans 1 years, with the latest figure at $45.4 million for Q4 2025.

  • For Q4 2025, Long-Term Investments changed N/A year-over-year to $45.4 million; the TTM value through Dec 2025 reached $45.4 million, changed N/A, while the annual FY2025 figure was $45.4 million, N/A changed from the prior year.
  • Long-Term Investments for Q4 2025 was $45.4 million at Beta Bionics, roughly flat from $45.3 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $64.0 million in Q1 2025 and bottomed at $31.1 million in Q2 2025.